Microarray analysis in Npc1-/- mouse cerebellum
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20450
下载链接
链接失效反馈官方服务:
资源简介:
Niemann-Pick Type C disease is an autosomal recessive neurodegenerative disorder with abnormal lipid storage as the major cellular pathologic hallmark. Genetic analyses have identified mutations in NPC1 gene in the great majority of cases, while mutations in NPC2 account for the remainders. Yet, little is known regarding the cellular mechanisms responsible for NPC pathogenesis, especially for neurodegeneration, which is the usual cause of death. To identify critical steps that could account for the pathological manifestations of the disease in one of the most affected brain structures, we performed global gene expression analysis in the cerebellum from three-week old Npc1+/+ and Npc1-/- mice with two different microarray platforms (Agilent and Illumina). Our results provide novel molecular insight regarding the mechanisms of pathogenesis in NPC disease and reveal potential new therapeutic targets. We performed global gene expression analysis in the cerebellum from three-week old Npc1+/+ and Npc1-/- mice with two different microarray platforms (Agilent and Illumina). Differentially-expressed genes identified by both microarray platforms were then subjected to KEGG pathway analysis. Expression of genes in six pathways was significantly altered in Npc1-/- mice; functionally, these signaling pathways belong to the following three categories: 1) steroid and terpenoid biosynthesis, 2) immune response, and 3) cell adhesion/motility. In addition, the expression of several proteins involved in lipid transport was significantly altered in Npc1-/- mice.
尼曼-匹克C型病(Niemann-Pick Type C disease)是一种常染色体隐性遗传的神经退行性疾病,以异常脂质贮积为主要细胞病理特征。遗传学分析显示,绝大多数病例存在NPC1基因(NPC1 gene)突变,剩余少数病例由NPC2基因(NPC2)突变所致。然而,目前对于该病致病的细胞机制,尤其是作为主要致死原因的神经退行性变机制,仍所知甚少。为明确在受累最显著的脑结构之一中可阐释该病病理表现的关键环节,我们采用安捷伦(Agilent)、因美纳(Illumina)两种不同的微阵列芯片平台,对3周龄Npc1+/+与Npc1-/-小鼠的小脑组织开展了全基因表达分析。本研究结果为NPC病的致病机制提供了全新的分子视角,并揭示了潜在的新型治疗靶点。我们采用安捷伦(Agilent)、因美纳(Illumina)两种不同的微阵列芯片平台,对3周龄Npc1+/+与Npc1-/-小鼠的小脑组织开展了全基因表达分析。随后,对两种芯片平台共同鉴定得到的差异表达基因进行了KEGG通路分析(KEGG pathway analysis)。Npc1-/-小鼠体内6条通路的基因表达发生显著改变;功能层面,这些信号通路可归为以下三类:1)类固醇与萜类生物合成通路,2)免疫应答通路,3)细胞黏附/运动通路。此外,Npc1-/-小鼠体内多种参与脂质转运的蛋白质表达亦出现显著异常。
创建时间:
2018-05-10



